Cardinal Health Inc (CAH) Q2 2025 Earnings Call Highlights: Strong Pharma Growth Amid Revenue ...
Cardinal Health Inc (CAH) raises EPS guidance despite a 4% revenue decline, driven by robust pharmaceutical segment performance and strategic acquisitions.
Cardinal Health, Inc. (NYSE:CAH) Q2 2025 Earnings Call Transcript
Q2 2025 Earnings Call Transcript January 30, 2025 Cardinal Health, Inc. beats earnings expectations. Reported EPS is $1.93, expectations were $1.74. Operator: Hello, and welcome to the Second Quarter Fiscal Year 2025 Cardinal Health Inc.
Cardinal Health (CAH) Projected to Post Quarterly Earnings on Thursday
Cardinal Health (NYSE:CAH – Get Free Report) is expected to be issuing its quarterly earnings data before the market opens on Thursday, January 30th. Analysts expect the company to announce earnings of $1.
Here's Why Cardinal Health (CAH) is a Strong Value Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why Did Cardinal Health Inc (CAH) Stock Surge 1.42% Last Week?
Cardinal Health Inc (CAH) stock saw a decline, ending the day at $128.83 which represents a decrease of $-0.47 or -0.36% from the prior close of $129.3. The stock opened at $129.47 and touched a low of $128.
Cardinal: Fiscal Q2 Earnings Snapshot
(CAH) on Thursday reported fiscal second-quarter earnings of $400 million. The Dublin, Ohio-based company said it had net income of $1.65 per share. Earnings, adjusted for one-time gains and costs, were $1.
Cardinal Health, Inc. (CAH) Q2 2025 Earnings Call Transcript
Hello, and welcome to the Second Quarter Fiscal Year 2025 Cardinal Health Inc. Earnings Conference Call. My name is George, and I'll be coordinator for today's event. Please note, this conference is being recorded.
Cardinal Health Inc Q2 Profit Increases, Beats Estimates
Cardinal Health Inc (CAH) revealed a profit for its second quarter that increased from last year and beat the Street estimates. The
Cardinal (CAH) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Cardinal Health (CAH) reported $55.26 billion in revenue for the quarter ended December 2024, representing a year-over-year decline of 3.8%. EPS of $1.93 for the same period compares to $1.82 a year ago.
Bank of America Securities Reaffirms Their Buy Rating on Cardinal Health (CAH)
Bank of America Securities analyst Allen Lutz maintained a Buy rating on Cardinal Health (CAH – Research Report) today. The company’s shares ...
Zacks.com on MSN22h
CAH Q2 Earnings and Sales Beat Estimates, 2025 EPS View Raised
Cardinal Health, Inc. CAH reported second-quarter fiscal 2025 adjusted earnings per share (EPS) of $1.93, which beat the ...
Cardinal Health (NYSE:CAH) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says
Cardinal Health (NYSE:CAH – Get Free Report) had its target price hoisted by equities researchers at Wells Fargo & Company from $127.00 to $135.00 in a research note issued on Wednesday,Benzinga ...
Cardinal Health price target raised to $154 from $149 at Baird
Baird raised the firm’s price target on Cardinal Health (CAH) to $154 from $149 and keeps an Outperform rating on the shares. Invest with ...
Seeking Alpha2d
CAH Cardinal Health, Inc.
View Cardinal Health, Inc. (CAH) current and estimated P/E ratio data provided by Seeking Alpha.